Literature DB >> 4855755

Specific heterologous enhancement of immune responses. VI. Partial purification of a nonspecific enhancing factor from supernates of allogeneically stimulated human lymphocyte cell lines.

A S Rubin, A B MacDonald, A H Coons.   

Abstract

The mixing of two histoincompatible human lymphocyte cell lines generated the release of a soluble factor which was capable of nonspecifically enhancing the in vitro immune response of normal mouse spleen cells against sheep erythrocytes. When active supernates were subjected to exclusion chromatography on Sephadex G-150 and BioGel P-150, the active principle eluted with molecules of approximately 35,000 mol wt. Column aliquots from similarly treated supernates from independent cultures of each lymphoid cell line were inactive. The human enhancing factor was concentrated and purified by ammonium sulfate fractionation, followed by Sephadex gel filtration and polyacrylamide gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4855755      PMCID: PMC2139523          DOI: 10.1084/jem.139.2.439

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Specific heterologous enhancement of immune responses. V. Isolation of a soluble enhancing factor from supernatants of specifically stimulated and allogeneically induced lymphoid cells.

Authors:  A S Rubin; A B MacDonald; A H Coons
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

Review 2.  The allogeneic effect on immune responses: model for regulatory influences of T lymphocytes on the immune system.

Authors:  D H Katz
Journal:  Transplant Rev       Date:  1972

Review 3.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

4.  Products of lymphoid cells in continuous culture.

Authors:  P R Glade; K Hirschhorn
Journal:  Am J Pathol       Date:  1970-09       Impact factor: 4.307

5.  Purification and characterization of lymphocyte mediators in cellular immunity: comparative studies on migration inhibitory factor (MIF) chemotactic factor for macrophages and lymphotoxin.

Authors:  H G Remold
Journal:  Transplant Rev       Date:  1972

6.  Specific heterologous enhancement of immune responses.

Authors:  A S Rubin; A H Coons
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

7.  Induction of a hemolysin response in vitro. Interaction of cells of bone marrow origin and thymic origin.

Authors:  K U Hartmann
Journal:  J Exp Med       Date:  1970-12-01       Impact factor: 14.307

8.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

  8 in total
  5 in total

1.  Partial characterization of an immunoenhancing factor from allogeneic human lymphocyte cell lines.

Authors:  A S Rubin; A B Macdonald
Journal:  Immunology       Date:  1976-01       Impact factor: 7.397

2.  Dextran-triggered T cells heighten T- and B-cell reactions to mitogens.

Authors:  Y G Alevy; J R Battisto
Journal:  Immunology       Date:  1976-03       Impact factor: 7.397

3.  Isolation and partial characterization of an antibody enhancing factor from leukaemic owl monkey cell cultures.

Authors:  A B MacDonald; C E Fraser; A S Rubin
Journal:  Immunology       Date:  1978-01       Impact factor: 7.397

4.  Purification and properties of a factor from leukaemic T cells which non-specifically enhances the antibody response.

Authors:  H L Mulcahy; A S Rubin; A B MacDonald
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

5.  Immunological functions of human T-lymphoid cell line (MOLT). I. Release of immunosuppressive factors from the mixture of MOLT-4 cells and sheep red blood cells.

Authors:  A Takada; Y Takada; J Minowada
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.